Literature DB >> 2179505

Expression of the VLA family of integrins in human intestine.

M Y Choy1, P I Richman, M A Horton, T T MacDonald.   

Abstract

The distribution of cells expressing the integrins VLA-1 to 6 in human intestine was examined by alkaline phosphatase immunohistochemistry using monoclonal antibodies specific for the individual alpha-chains of the VLA heterodimer. VLA-2,3, and 6 were expressed on all epithelial cells in the small and large bowel. VLA-1 was expressed on crypt cells in the small and large bowel, but was only weakly expressed or was absent on villus epithelial cells in the small bowel and colonic surface epithelial cells. All epithelia were negative for VLA-4 and VLA-5. Intraepithelial lymphocytes were VLA-1+ and VLA-4+. VLA-1,3, and 5 were expressed uniformly by muscularis propria, muscularis mucosae, pericrypt cells, and smooth muscle fibres within the villi. By contrast, VLA-2 and 4 were present only in pericrypt cells and fibres within the villi; they were absent from the muscularis mucosae. VLA-1,3,5, and 6 were expressed by endothelium. Staining of muscle fibres and endothelium in the lamina propria made it difficult to determine the extent of VLA expression on lamina propria lymphocytes. However, VLA-1+ cells with lymphoid morphology were only rarely seen. All mononuclear cells in the lamina propria were VLA-4+.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179505     DOI: 10.1002/path.1711600109

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  24 in total

1.  Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.

Authors:  Peter Halasz; Gavan Holloway; Stephen J Turner; Barbara S Coulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

2.  Integrin alpha1beta1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen.

Authors:  A I Roberts; R E Brolin; E C Ebert
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  The absence of accessible vitronectin receptors in differentiated tissue hinders adenoviral-mediated gene transfer to the intestinal epithelium in vitro.

Authors:  E Walter; M A Croyle; B J Roessler; G L Amidon
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

4.  Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype.

Authors:  S L Pender; M T Salmela; G Monteleone; D Schnapp; C McKenzie; J Spencer; S Fong; U Saarialho-Kere; T T MacDonald
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 5.  Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors.

Authors:  M Streit; R Schmidt; R U Hilgenfeld; E Thiel; E D Kreuser
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

6.  P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.

Authors:  Merit E Reyes-Reyes; Margaret D George; John D Roberts; Steven K Akiyama
Journal:  Exp Cell Res       Date:  2006-09-16       Impact factor: 3.905

Review 7.  Extracellular matrix components in intestinal development.

Authors:  P Simon-Assmann; M Kedinger; A De Arcangelis; V Rousseau; P Simo
Journal:  Experientia       Date:  1995-09-29

Review 8.  Integrins: cell adhesives and modulators of cell function.

Authors:  F T Bosman
Journal:  Histochem J       Date:  1993-07

9.  Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas.

Authors:  M Miettinen; R Castello; E Wayner; R Schwarting
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

10.  Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies.

Authors:  M Vorkauf; G Duncker; B Nölle; W Sterry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.